A Novel Pregabalin Functionalized Salicylaldehyde Derivative Afforded Prospective Pain, Inflammation, and Pyrexia Alleviating Propensities

Archiv der Pharmazie
Nisar AhmadKhwaja Fawad

Abstract

A novel pregabalin derivative named as pregsal ((S,E)-3-(((2-hydroxybenzylidene)amino)methyl)-5-methylhexanoic acid) was synthesized by a simple imination reaction between pregabalin and salicylaldehyde and was evaluated in the in vivo testing paradigms. The compound was characterized by UV, IR, 1 H, 13 C NMR, HR ESI-MS, and elemental analysis. It was screened (30, 50, 75, and 100 mg/kg) for antinociceptive, anti-inflammatory, and antipyretic activities in relation to pregabalin. The synthesized compound significantly attenuated the tonic acetic acid-induced nociceptive pain (30 mg/kg (P < 0.05), 50 mg/kg (P < 0.01), 75 and 100 mg/kg (P < 0.001)), and thermal-induced hyperalgesia (P < 0.001). These activities were succinctly antagonized (P < 0.05, P < 0.01, P < 0.001) by naloxone and pentylenetetrazole, implicating the involvement of opioidergic and GABAergic mechanisms. The compound also inhibited the temporal inflammatory response and alleviated the yeast-induced pyrexia (P < 0.05, P < 0.01, and P < 0.001). These findings suggest that the synthesized compound possessed prospective pain, inflammation, and pyrexia relieving propensities and therefore may serve as a potential drug candidate for the therapeutic management of chro...Continue Reading

References

Jun 13, 1991·The New England Journal of Medicine·P M Brooks, R O Day
Feb 1, 1968·British Journal of Pharmacology and Chemotherapy·H O CollierC Schneider
Mar 1, 1995·General Pharmacology·H W ColeH U Bryant
Jun 1, 1994·Chronobiology International·B Bruguerolle, X Roucoules
Jan 1, 1997·Acta Anaesthesiologica Scandinavica·T L Yaksh
Apr 18, 1997·European Journal of Pharmacology·J C HunterD J Fontana
Mar 18, 2000·European Journal of Pharmacology·J I MobarakehK Yanai
Jun 15, 2001·ILAR Journal·T.J. Ness
Sep 22, 2001·The American Journal of Medicine·D M Aronoff, E G Neilson
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Tinna M LaughlinAngela K Birnbaum
Dec 1, 1962·Proceedings of the Society for Experimental Biology and Medicine·C A WINTERG W NUSS
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Alan B Ettinger, Charles E Argoff
Dec 7, 2007·Anesthesiology Clinics·Helena Knotkova, Marco Pappagallo
Jan 4, 2008·Nature Reviews. Drug Discovery·Robin L ThurmondPaul J Dunford
Jan 5, 2010·Psychiatry Investigation·David M MarksChi-Un Pae
Jan 21, 2010·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M JutelC A Akdis
Mar 6, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Izabela RozenbergFelix C Tanner
Jun 10, 2011·European Journal of Pharmacology·Zheng LiSean Donevan
Aug 17, 2011·Journal of Infection and Public Health·Dimie Ogoina
May 17, 2012·Acta Crystallographica. Section E, Structure Reports Online·S K S HazariTapashi G Roy
Nov 8, 2012·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Manzumeh Shamsi Meymandi, Fariborz Keyhanfar
Feb 18, 2014·Neurochemical Research·Kenneth E McCarson, S J Enna
Feb 18, 2014·Current Neuropharmacology·Vivek VermaAmteshwar Singh Jaggi
Jul 22, 2016·Heliyon·Muhammad ShahidRehmat Shah

❮ Previous
Next ❯

Citations

Oct 21, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Muhammad ShahidZia Ud Din
Oct 1, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Muhammad ShahidRobert D E Sewell
Aug 14, 2020·European Journal of Pharmacology·Lala RukhMuhammad Shahid

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here